AsiaFIN ( ASFH ) FY 2025 Net loss was ~$120K for the year ended December 31, 2025 vs. $162K last year. Revenue for the years ended December 31, 2025 and 2024 was approximately $5.126M and $3.382M, respectively. This represents a growth of 51.5% in the year 2025. Cash and cash equivalents were approximately $1.748M as of December 31, 2025. "Our Fintech business has recorded revenue growth of 52% fr...
AsiaFIN ( ASFH ) FY 2025 Net loss was ~$120K for the year ended December 31, 2025 vs. $162K last year. Revenue for the years ended December 31, 2025 and 2024 was approximately $5.126M and $3.382M, respectively. This represents a growth of 51.5% in the year 2025. Cash and cash equivalents were approximately $1.748M as of December 31, 2025. "Our Fintech business has recorded revenue growth of 52% from 2024, showing that the cheque clearing business can still deliver growth in our new markets. Our core revenue-generating unit, RegTech, continues to grow well, with gross margins improving by 13.46%. As we enter 2026, we are seeing traction in our Fintech and RegTech businesses whilst we are gaining new customers in our RPA business." said CEO Kai Cheong Wong. More on AsiaFIN Holdings Corp. Financial information for AsiaFIN Holdings Corp.
Dow, S&P 500, Nasdaq Futures Slide After Trump Says US Will Hit Iran ‘Extremely Hard’ For Weeks: Why DJT, USO, TSLA, NVDA, MSTR Are In Focus Stocktwits
Dow, S&P 500, Nasdaq Futures Slide After Trump Says US Will Hit Iran ‘Extremely Hard’ For Weeks: Why DJT, USO, TSLA, NVDA, MSTR Are In Focus Stocktwits
An innovative therapy using pig semen-derived exosomes, engineered into eye drops capable of penetrating deep into retinal tissue, may hold the key to breaching the brain’s defences against diseases like Alzheimer’s. This breakthrough, led by Professor Zhang Yu at China’s Shenyang Pharmaceutical University, originally targeted a rare childhood eye cancer retinoblastoma that often resists conventio...
An innovative therapy using pig semen-derived exosomes, engineered into eye drops capable of penetrating deep into retinal tissue, may hold the key to breaching the brain’s defences against diseases like Alzheimer’s. This breakthrough, led by Professor Zhang Yu at China’s Shenyang Pharmaceutical University, originally targeted a rare childhood eye cancer retinoblastoma that often resists conventional treatments due to its delicate location near the brain. Published in peer-reviewed journal...
Ayatollah Breaks Silence, In Written Message Praises Hezbollah & Shia Leaders Of Iraq The new, younger Ayatollah Khamenei - who may have been wounded in the early days of US-Israeli strikes, hasn't been seen in any public way, not even on TV, throughout the war . There have not so much as been any official recent images of him circulated. But Mojtaba Khamenei has apparently been issuing some limit...
Ayatollah Breaks Silence, In Written Message Praises Hezbollah & Shia Leaders Of Iraq The new, younger Ayatollah Khamenei - who may have been wounded in the early days of US-Israeli strikes, hasn't been seen in any public way, not even on TV, throughout the war . There have not so much as been any official recent images of him circulated. But Mojtaba Khamenei has apparently been issuing some limited written statements , mainly encouraging foreign proxies in their joining the war against US and Israeli forces in the region. State media has indicated he's not making public appearances given the ongoing relentless bombing campaign and the Islamic Republic's wartime footing. via PressTV After a long period of relative silence, a message from Khamenei was publicized on Monday. In the message attributed to him, he "expressed his appreciation to the supreme religious authority (in Iraq) and the people of Iraq for their clear stance against aggression against Iran and their support for our country," Iran’s ISNA news agency said, referring to the Iraq-based Grand Ayatollah Ali Sistani. Sistani is based in Iraq and has long been a highly revered Shia cleric in the region. The 56-year old Khamenei has on Wednesday apparently broken his silence again, this time praising Hezbollah for joining the war against Israel. Hezbollah has been launching hundreds of rockets on northern and central Israel, amid an emerging ground campaign in southern Lebanon, also as Israel bombs Beirut from the air. In the new words carried by Iranian state media, he praised Hezbollah for its "perseverance, steadfastness and patience" against "the most ruthless enemies of the Islamic world." Meanwhile, the CIA and Mossad are said to be trying to uncover Mojtaba Khamenei's whereabouts and status. His 86-year old father did not appear to have been in hiding at all when he was slain by airstrike on the very first day of Operation Epic Fury. The most likely explanation could be that the younger Khamenei is di...
One of Hong Kong’s most high-profile insider trading cases began after compliance staff at Bank of America Corp. , the firm arranging a block trade, flagged concerns about handling price-sensitive information that wasn’t public. The new details emerged on Thursday in a Hong Kong District Court hearing ahead of the high-profile insider trading trial involving Segantii Capital Management and its fou...
One of Hong Kong’s most high-profile insider trading cases began after compliance staff at Bank of America Corp. , the firm arranging a block trade, flagged concerns about handling price-sensitive information that wasn’t public. The new details emerged on Thursday in a Hong Kong District Court hearing ahead of the high-profile insider trading trial involving Segantii Capital Management and its founder, Simon Sadler, once known as Hong Kong’s “block trade king.” Wayne Walsh, the lawyer representing the Wall Street bank, won a request to have the hearing closed to the public temporarily while sensitive documents were discussed. Walsh argued some material was provided to the regulator on a “limited waiver” for its supervisory and regulatory functions and shouldn’t be used by the defense. The court was presided over by Judge Josiah Lam. The trial of the Hong Kong-based hedge fund firm Segantii, Sadler and former trader Daniel La Rocca is set to begin May 4 and is estimated to last 25 days. It’s expected to shine a light on sales of blocks of shares that happen away from exchanges, an often opaque process. Since criminal proceedings began in 2024, the city’s securities watchdog has sought to tighten scrutiny on how confidential price-sensitive information is shared between banks and their clients ahead of such deals. Hong Kong’s Securities and Futures Commission accused the trio of trading $1.14 million worth of shares of fashion retailer Esprit Holdings Ltd. before US hedge fund firm Lone Pine Capital’s June 2017 sale of a 10% stake. They allegedly received inside information on the upcoming deal from Tony Psarianos, whose regulatory records showed him to be employed by Bank of America’s Merrill Lynch unit at the time. Bank of America’s Merrill Lynch unit handled the Lone Pine stake sale and is not a defendant in this case. Psarianos and another former Merrill Lynch trader Anshul Trivedi are key witnesses in the trial, the court was previously told. Walsh on Thursday sa...
The newly announced sanctions relief is the latest U.S. recognition of Rodríguez as a legitimate authority in Venezuela ever since the U.S. military captured her predecessor, Nicolás Maduro. (Image credit: Ariana Cubillos)
The newly announced sanctions relief is the latest U.S. recognition of Rodríguez as a legitimate authority in Venezuela ever since the U.S. military captured her predecessor, Nicolás Maduro. (Image credit: Ariana Cubillos)
Shanghai StairMed Technology Co., Ltd. ("StairMed" or "the Company") recently announced the closing of a strategic financing round totaling RMB 500 million. The round was led by Alibaba, with strong continued participation from existing shareholders including Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Ventures (LAV), and Source Code Capital, etc. Spri...
Shanghai StairMed Technology Co., Ltd. ("StairMed" or "the Company") recently announced the closing of a strategic financing round totaling RMB 500 million. The round was led by Alibaba, with strong continued participation from existing shareholders including Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Ventures (LAV), and Source Code Capital, etc. Springhill Fund served as the exclusive financial advisor. This latest round brings StairMed's total fun